INSM
Insmed Incorporated
NASDAQ · Healthcare · Biotechnology · US
$126.29
−0.31%Margins
Gross margin
83.3%
EBITDA margin
-67.7%
EBIT margin
-71.9%
Net margin
-76.9%
FCF margin
-73.6%
-115.6%
Return on equity
-41.6%
Return on assets
-61.1%
Return on invested capital
0.54x
Asset turnover
-$778.9M
Cash from operations
$5.31
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026